A startup that develops and provides new clinical testing services using genome technology. In the field of fertility, we focused on the endometrial microbiome, which affects the success rate of pregnancy. In Japan, it has been introduced at more than 250 medical institutions, mainly fertility clinics. There are only a few companies in the world that are able to analyze ultra-low biomass samples of bacteria in the uterus and have put it to practical use as a clinical testing. In the future, we will promote the provision of testing in countries around the world, mainly in Asia and Europe.